Starry Sea Acquisition Corp (SSEA) Stock Analysis

$10.300

0.000 (0.00%)At close

Loading chart…

High: 10.300
Open: 10.300
VWAP: —
Vol: 0.00
Mkt Cap: —
Low: 10.300
Amount: 0.00
EV/EBITDA, TTM: 0.00

Starry Sea Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.

AI analysis of Starry Sea Acquisition Corp (SSEA)

hold

Starry Sea Acquisition Corp is currently not a strong buy due to its low RSI of 37.437, indicating it is nearing oversold territory, but it has not yet reached a buying signal. Additionally, the forward P/E ratio is 0, suggesting uncertainty about future earnings. The recent merger with SuperiorMed could provide potential upside, but the stock's performance has been stagnant with a 5-day change of -0.10%.

Valuation Metrics

The current forward P/E ratio for Starry Sea Acquisition Corp (SSEA) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued

5Y Average P/E

0.00

Current P/E

0.00

Overvalued

0.00

Undervalued

0.00

Forward EV/EBITDA

Strongly Undervalued

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued

0.00

Undervalued

0.00

Forward P/S

Fair

5Y Average P/S

0.14

Current P/S

0.00

Overvalued

1.33

Undervalued

-1.04

News

SSEA FAQ — answered by Alphio AI

Starry Sea Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. It operates in the Financials sector.

Starry Sea Acquisition Corp is currently not a strong buy due to its low RSI of 37.437, indicating it is nearing oversold territory, but it has not yet reached a buying signal. Additionally, the forward P/E ratio is 0, suggesting uncertainty about future earnings. The recent merger with SuperiorMed could provide potential upside, but the stock's performance has been stagnant with a 5-day change of -0.10%.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.